According to Biolife Solutions
's latest financial reports the company has $0.33 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.33 B | -7.28% |
2022-12-31 | $0.36 B | -23.82% |
2021-12-31 | $0.47 B | 132.91% |
2020-12-31 | $0.20 B | 372.33% |
2019-12-31 | $43.45 M | 196.98% |
2018-12-31 | $14.63 M | 44.99% |
2017-12-31 | $10.09 M | 218.75% |
2016-12-31 | $3.16 M | -67.89% |
2015-12-31 | $9.85 M | -29.25% |
2014-12-31 | $13.93 M | -205.01% |
2013-12-31 | $-13.28 M | 6.29% |
2012-12-31 | $-12.49 M | 11.68% |
2011-12-31 | $-11.19 M | 17.09% |
2010-12-31 | $-9.55 M | 22% |
2009-12-31 | $-7.83 M | 51.36% |
2008-12-31 | $-5.18 M | 109.37% |
2007-12-31 | $-2.47 M | -1471.42% |
2006-12-31 | $0.18 M | 368% |
2005-12-31 | $0.03 M | -93.72% |
2004-12-31 | $0.61 M | -54.8% |
2003-12-31 | $1.35 M | -344.68% |
2002-12-31 | $-0.56 M | -278.35% |
2001-12-31 | $0.31 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Celanese CE | $7.55 B | 2,136.55% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $0.19 B | -43.17% | ๐บ๐ธ USA |
Amyris AMRS | -$0.65 B | -291.93% | ๐บ๐ธ USA |